0001171843-22-005617.txt : 20220811
0001171843-22-005617.hdr.sgml : 20220811
20220811161149
ACCESSION NUMBER: 0001171843-22-005617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220810
FILED AS OF DATE: 20220811
DATE AS OF CHANGE: 20220811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levitz Michael L
CENTRAL INDEX KEY: 0001468019
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 221155973
MAIL ADDRESS:
STREET 1: C/O ANALOGIC CORPORATION
STREET 2: 8 CENTENNIAL DRIVE
CITY: PEABODY
STATE: MA
ZIP: 01960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0306
4
2022-08-10
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001468019
Levitz Michael L
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
EVP, CFO, Treasurer
Common Stock
2022-08-10
4
M
0
3859
0
A
20423
D
Restricted Stock Unit
0.00
2022-08-10
4
M
0
3859
0
D
Common Stock
3859
3859
D
Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest.
Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021.
/s/ Michael L. Levitz
2022-08-11